Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Intersecting clinical, genomic, and experimental investigation to understand the mechanisms and impact of coronary artery patterning

Award Number: R01HL171326
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/01/2024
PERIOD OF PERFORMANCE END DATE: 07/31/2028

Group Awards By:

View Award Description

Intersecting clinical, genomic, and experimental investigation to understand the mechanisms and impact of coronary artery patterning - PROJECT SUMMARY/ABSTRACT Coronary artery disease (CAD) remains a leading cause of death despite the availability of lifesaving pharma- cological and mechanical interventions. Complementary treatments are desperately needed, particularly for individuals with advanced disease. Here, we propose foundational work toward realizing a hypothetical `medi- cal revascularization' that could one day help patients with CAD by extending coronary arterial networks or in- ducing natural bypasses through collateral arteries. An obstacle to `medical revascularization' is the lack of known targetable pathways that can stimulate coronary artery growth and collateralization. Our principal ra- tionale for overcoming this knowledge gap—based on our prior research individually and as a team—is that studying coronary artery formation during embryonic and fetal development should identify pathways for re- forming coronary arteries during disease. Since coronary development generates variations in anatomy, we propose to identify regenerative pathways by studying the human population genetics of coronary artery ana- tomical variation, or patterning, and then investigating the utility of identified genetic regulators using pre-clini- cal experimentation. Our long-term goal is to use this information to develop new translational pathways. We will first accurately classify three coronary patterning phenotypes routinely documented during coronary angi- ography in the Veteran Affairs Health Care System, including anomalous coronary arteries, coronary domi- nance, and coronary collateralization, and assess their impact on clinical cardiovascular outcomes nationwide (Aim 1). Next, we will cross reference this dataset with the Million Veteran Program to identify the genetic de- terminants through genome wide association studies (GWAS) in >90,000 participants of diverse ancestry, in- cluding >16,000 African and >6,000 Hispanic American Veterans. Genetic discovery will be extended into the multi-ancestry Penn Medicine Biobank through replication and meta-analysis. Downstream analyses on GWAS summary statistics will identify the most compelling candidate causal genes at each susceptibility locus (Aim 2). The function of prioritized candidate genes will be comprehensively tested using mouse genetic manipula- tions in developmental and injury models and a novel human iPSC-to-artery differentiation method (Aim 3). The project is innovative because it leverages a combination of the nation's largest integrated health care sys- tem, the oldest electronic health record system—including one of the most comprehensive registries of coro- nary catheterization procedures—and the world's largest active biobank to conduct translational research. Ad- ditionally, candidate genes will be experimentally validated in developmental and pre-clinical assays for coro- nary artery and collateral formation. This research is significant because it will set the stage for the develop- ment of novel therapies able to promote the growth of arteries that could substantially improve both the quality and quantity of life in individuals suffering from CAD.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $654,145 )
2025	2025	PALO ALTO VETERANS INSTITUTE FOR RESEARCH	3801 MIRANDA AVE	PALO ALTO	CA	94304	SANTA CLARA	USA	Cardiovascular Diseases Research	000	2	8/2/2025	NON-COMPETING CONTINUATION	$654,145
														Subtotal = $654,145

Issue Date FY: 2024 ( Subtotal = $703,368 )
2024	2024	PALO ALTO VETERANS INSTITUTE FOR RESEARCH	3801 MIRANDA AVE	PALO ALTO	CA	94304	SANTA CLARA	USA	Cardiovascular Diseases Research	001	1	9/9/2024	NEW	$0
2024	2024	PALO ALTO VETERANS INSTITUTE FOR RESEARCH	3801 MIRANDA AVE	PALO ALTO	CA	94304	SANTA CLARA	USA	Cardiovascular Diseases Research	000	1	7/16/2024	NEW	$703,368
														Subtotal = $703,368

Grand Total All Awards = $1,357,513

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Intersecting clinical, genomic, and experimental investigation to understand the mechanisms and impact of coronary artery patterning

Award Number: R01HL171326

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/01/2024

PERIOD OF PERFORMANCE END DATE: 07/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer